HOVON HO168 NHL
Gepland
Main info
- Identificatie:
- HO168-DLBCL
- Sponsor:
- HOVON
- Working group party:
- Lymphoma
- Stadium:
- 1st lijn
- Echelon:
- Level D
- Included patients:
-
0(of 276)
- Active sites:
-
0(of 60)31 sites are pending
- Title:
Epcoritamab in Addition to R-Mini-CHOP Compared to R-Mini-CHOP in Elderly
Frail or Unfit Patients with Diffuse Large B-cell Lymphoma
Timeline
Scheduled
Actual
2022
21 jun.
Opportunity
2024
04 mrt.
Development
2026
31 mrt.
Submission in Progress
2026
11 mei
Submission in Progress
2026
30 sep.
Activated
2026
05 okt.
EC Approval
2026
15 okt.
First Site
2026
30 okt.
FPI
2029
28 sep.
ClosedForInclusionScheduledStart
2031
19 dec.
Closeout in Progress
2032
16 feb.
Endpoint Analysis
2032
30 apr.
Archived
Details
- Phase:
- Prospective randomized Phase II study
- Monitoring Type:
- HOVON Monitoring Visit
- Objectives:
Participating Sites
Site
31 results
Order by
Accrual rate
Activation date
NL-Delft-RDGG
IE-Dublin 7-MATER
IE-Dublin 8-STJAMES
IE-Galway-UHGALWAY
IE-Dublin 9-BEAUMONT
PT-Lisboa-IPOLISBOA
PT-Coimbra-COIMBRAUH
PT-Lisboa-DESANTAMARIA
BE-Brasschaat-KLINA
IE-Waterford City-WATERFORD
HR-Split-KBC
HR-Zagreb-MERKUR
HR-Zagreb-SOC
HR-Zagreb-DUBRAVA
IE-Limerick-UHL
NL-Emmen-SCHEPER
BE-Gent-UZGENT
NL-Den Bosch-JBZ
NL-Groningen-UMCG
NL-Leeuwarden-MCL
NL-Nieuwegein-ANTONIUS
BE-Leuven-UZLEUVEN
NL-Deventer-DZ
NL-Hoofddorp-SPAARNEGASTHUIS
NL-Dordrecht-ASZ
NL-Almere-FLEVOZIEKENHUIS
NL-Arnhem-RIJNSTATE
NL-Rotterdam-SFG
NL-Uden-BERNHOVEN
BE-Brugge-AZBRUGGE
HR-Zagreb-UHCZ
= Active hospitals 
= Inactive hospitals